SCHEMBL4376889

SCHEMBL4376889

CCOC(=O)c1nc(Cl)nc2c1NC(=O)CN2c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 5/20 0.45
HSD17B10 Q99714 2/20 0.45
HPGD P15428 1/20 0.45
ALOX12 P18054 2/20 0.42
TP53 P04637 1/20 0.42
GABRA2 P47869 3/20 0.42
GABRB2 P47870 3/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
CASP3 P42574 1/20 0.41
ADORA1 P30542 2/20 0.41
ADORA2A P29274 1/20 0.41
GAA P10253 2/20 0.41
KDM4A O75164 1/20 0.41
USP2 O75604 1/20 0.41
MPI P34949 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
MAPT P10636 3/20 0.39
APP P05067 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16504846 0.68 KDM4E (0.53) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL16330423 0.67 TP53 (0.57) ALDH1A1KDM4EHSD17B10HPGDALOX12
SCHEMBL16504996 0.65 PDE4A (0.47) ALDH1A1KDM4EHSD17B10HPGDNPC1
SCHEMBL28728715 0.64 NPC1 (0.62) ALDH1A1KDM4EHSD17B10HPGDALOX12
SCHEMBL9153563 0.64 MAPT (0.49) ALDH1A1KDM4EHSD17B10HPGDALOX12
SCHEMBL17902649 0.63 CASP3 (0.56) ALDH1A1KDM4EHSD17B10HPGDNPC1
SCHEMBL9208732 0.63 CASP3 (0.66) ALDH1A1KDM4EHSD17B10HPGDCASP3
SCHEMBL10374929 0.63 TP53 (0.75) ALDH1A1KDM4EHSD17B10HPGDALOX12
SCHEMBL3494358 0.63 ALDH1A1 (0.54) ALDH1A1ALOX12TP53GABRA2GABRB2
SCHEMBL1078509 0.62 TP53 (0.58) ALDH1A1KDM4EHSD17B10HPGDALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078018-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051494-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed